Animal experiments show that SGLT2 inhibitors can reduce the mortality of myocardial infarction in diabetic mice through cardiac energy metabolism and protective modification of antioxidant proteins, suggesting that hyperglycemia is associated with energy metabolism disorder and oxidative stress in myocardial infarction [28]. This evidence concerns the gene SLC5A2 and Hyperglycemia.